Results

Total Results: 277 records

Showing results for "occurrence".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/pneumonia-antibiotic-treatment_research-protocol.pdf
    July 19, 2013 - o KQ 1a, KQ 2a, and KQ 3: Intermediate outcomes  Clinical response  Mechanical ventilation (occurrence … Susceptibility (KQ 3)     Intermediate Outcomes • Clinical response • Mechanical ventilation (occurrence … Outcomes • KQ 1a, KQ 2a, and KQ 3 o Intermediate:  Clinical response  Mechanical ventilation (occurrence
  2. effectivehealthcare.ahrq.gov/sites/default/files/06_devdelays_autism_potential_high_impact_june_2012.pdf
    January 01, 2012 - increasing, and recent estimates place the prevalence at about 1% of children in the United States, with occurrence
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-quality-meaures_research.pdf
    April 01, 2010 - Importantly, the occurrence of several of these benchmarks was similar across the cohorts defined by … was positively associated with the receipt of chemotherapy (6a), the receipt of opiates (6b), the occurrence … oncologist was independently associated with the receipt of chemotherapy, the receipt of opiates, and the occurrence … Several characteristics of the treating oncologist were not significantly associated with the occurrence … Association of physician and hospital characteristics on the occurrence of chemotherapy toxicity Model
  4. effectivehealthcare.ahrq.gov/sites/default/files/ch_10-user-guide-to-ocer_130129.pdf
    January 01, 2011 - Disease risk scores estimate the probability or rate of disease occurrence as a function of the covariates … However, the DRS estimates the probability or rate of disease occurrence as a function of the covariates
  5. effectivehealthcare.ahrq.gov/sites/default/files/study-design-considerations-chapter-2.pptx
    January 01, 2013 - their exposure at a certain point in time (i.e., baseline date) and are followed over time for the occurrence … exposure at a certain point in time (the baseline date) and are followed over time after baseline for the occurrence
  6. effectivehealthcare.ahrq.gov/sites/default/files/mccormack-presentation.pdf
    October 08, 2025 - McCormack-notes-151008 copy - Teresa My talk today is about engaging patients with  low health  literacy. 1 Health literacy is a key factor in securing access to healthcare services. So in my talk today, I’ll talk a little bit about health literacy and what it is, how we measure health literacy and the sta…
  7. effectivehealthcare.ahrq.gov/sites/default/files/ch_6-user-guide-to-ocer_130129.pdf
    October 30, 2012 - treatments are developed and must demonstrate efficacy in preapproval clinical trials to prevent the occurrence … first or new diagnosis of the condition of interest), prevalent (existing disease), or recurrent (new occurrence … effectiveness in SLE, such as reduction or increase in time to flare, reduction in corticosteroid use, or occurrence … instances, additional information must be collected (usually from medical records) to validate the occurrence
  8. effectivehealthcare.ahrq.gov/sites/default/files/ch_9-user-guide-to-ocer_130129.pdf
    September 21, 2012 - assumptions about the standard deviation of the outcome in each trial arm; when the outcome is the occurrence
  9. effectivehealthcare.ahrq.gov/sites/default/files/frazee-presentation.pdf
    October 08, 2025 - you have to remember as human beings that it wasn't that long ago where famine was a pretty regul ar occurrence
  10. Table 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-indicators-symposium_research.pdf
    April 01, 2010 - • Begin by simply documenting whether the conversation occurred and then measuring the rate of occurrence … understanding; • Determine key elements of the discussions about goals of care and then measure the rate of occurrence
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/vaccine-safety_research-protocol.pdf
    September 18, 2012 - • Was the mode of harms collection active (participants are asked about the occurrence of specific … AEs) or passive (participants are not specifically asked about or tested for the occurrence of AEs;
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/congestive-heart-failure-medicines_research.pdf
    March 01, 2010 - time varying covariate also accounted for gaps in H-ISDN therapy or cessation of therapy prior to the occurrence … to the diagnosis of HF to define comorbidities, and thus did not assess the severity of HF or the occurrence
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy-2011_research.pdf
    January 01, 2011 - Reference period (time of occurrence) in a definition of the outcome. … Reference period (time of occurrence) in a definition of the outcome. … independent of health care) Other (please specify) A-11 Reference period (time of occurrence … mining of the data collected for health care purposes) Minor flaw Reference period (time of occurrence … evaluation independent of health care) -0.05 0.66 0.90 0.07* Reference period, the time of the occurrence
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/trauma-interventions-maltreatment-child_research-protocol.pdf
    January 12, 2012 - The timing of its occurrence—in critical windows of development during childhood, when self-definition … Gateway, 27 primary prevention approaches are defined as having a universal focus to prevent the occurrence … Secondary prevention targets families with risk factors associated with maltreatment to prevent their occurrence
  15. S96 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s96.pdf
    October 01, 2007 - Representativeness Representativeness refers to the ability of a surveillance system to describe the occurrence
  16. 8 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_chou_assessing_harms_when_comparing.pdf
    November 01, 2008 - important an issue in case-control and cohort studies as when evaluating beneficial effects because their occurrence … Participants are asked in structured questionnaires or interviews about the occurrence of specific adverse … Passive surveillance of harms Participants are not specifically asked about or tested for the occurrence
  17. 8 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-harms_methods.pdf
    November 01, 2008 - important an issue in case-control and cohort studies as when evaluating beneficial effects because their occurrence … Participants are asked in structured questionnaires or interviews about the occurrence of specific adverse … Passive surveillance of harms Participants are not specifically asked about or tested for the occurrence
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccines-safety-protocol-130325.pdf
    September 18, 2012 - • Was the mode of harms collection active (participants are asked about the occurrence of specific … AEs) or passive (participants are not specifically asked about or tested for the occurrence of AEs;
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-patient-family-engagement.pdf
    July 01, 2023 - their families are the ones who experience safety events and are often most equipped to detect their occurrence
  20. S5 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s5.pdf
    October 01, 2007 - analyze ADEs and their severity and impact; controlling confounding by factors that influ- ence the occurrence

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: